Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • seqse
    Junior Member
    • Jan 2014
    • 2

    #1

    statistical justification of partitioning dataset for multiple analysis (EdgeR)

    Dear all,

    I'm doing analysis on allready mapped reads from sequencing data for differential expression with EdgeR. My experimental setup is as follow. I have samples from 4 different subjects. Material of each subject wast treated with 2 different treatments (and a control) for 2 timepoints.

    I want to analyse the effect of the treatments (compared to control and compared to eachother)

    In EdgeR I used following design
    model.matrix(~ subject+ Treatment + Time +Treatment : Time)

    I considered 2 strategies to analye te data:
    Estimate parameters from above mentioned design with all data (all samples) and use different contrasts to get the differential expressed genes I want.

    OR

    Use only the samples of the two treatments (eg. control vs treatment1, treatment 1 vs treatment 2) I want to compare to fit the parameters. So using only 2/3 of all data. Repeat the previous 3 times till I have compared all 3 treatments with eachother. So exctually 3 different analysis using only a subset of the data.

    I noticed that I could find considerably more significant differential expressed genes between 2 treatments with the last approach. But I wondered how correct this approach is? Will I have for example problems with multiple testing? (I control each analysis on fdr 5% with bejamin Hochberg)

    thanks in advance
    Kind regards

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
28 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
20 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
38 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
44 views
0 reactions
Last Post SEQadmin2  
Working...